<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">24608085</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1999-4915</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Viruses</Title>
                <ISOAbbreviation>Viruses</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evidence showing that tetraspanins inhibit HIV-1-induced cell-cell fusion at a post-hemifusion stage.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1078-90</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/v6031078</ELocationID>
            <Abstract>
                <AbstractText>Human immunodeficiency virus type 1 (HIV-1) transmission takes place primarily through cell-cell contacts known as virological synapses. Formation of these transient adhesions between infected and uninfected cells can lead to transmission of viral particles followed by separation of the cells. Alternatively, the cells can fuse, thus forming a syncytium. Tetraspanins, small scaffolding proteins that are enriched in HIV-1 virions and actively recruited to viral assembly sites, have been found to negatively regulate HIV-1 Env-induced cell-cell fusion. How these transmembrane proteins inhibit membrane fusion, however, is currently not known. As a first step towards elucidating the mechanism of fusion repression by tetraspanins, e.g., CD9 and CD63, we sought to identify the stage of the fusion process during which they operate. Using a chemical epistasis approach, four fusion inhibitors were employed in tandem with CD9 overexpression. Cells overexpressing CD9 were found to be sensitized to inhibitors targeting the pre-hairpin and hemifusion intermediates, while they were desensitized to an inhibitor of the pore expansion stage. Together with the results of a microscopy-based dye transfer assay, which revealed CD9- and CD63-induced hemifusion arrest, our investigations strongly suggest that tetraspanins block HIV-1-induced cell-cell fusion at the transition from hemifusion to pore opening.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Symeonides</LastName>
                    <ForeName>Menelaos</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, VT 05405, USA. mlambele@uvm.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lambel√©</LastName>
                    <ForeName>Marie</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA. mlambele@uvm.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roy</LastName>
                    <ForeName>Nathan H</ForeName>
                    <Initials>NH</Initials>
                    <Affiliation>Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, VT 05405, USA. mlambele@uvm.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thali</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, VT 05405, USA. mthali@uvm.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>5R01 AI080302</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 AI055402-06</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>03</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Viruses</MedlineTA>
            <NlmUniqueID>101509722</NlmUniqueID>
            <ISSNLinking>1999-4915</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2010 May 7;285(19):14681-8</RefSource>
                <PMID Version="1">20197275</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Retrovirology. 2009;6:64</RefSource>
                <PMID Version="1">19602278</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Traffic. 2010 Nov;11(11):1401-14</RefSource>
                <PMID Version="1">20727121</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2010 Nov 24;143(5):789-801</RefSource>
                <PMID Version="1">21111238</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>AIDS Res Hum Retroviruses. 2011 Sep;27(9):1013-7</RefSource>
                <PMID Version="1">21338326</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2011 Oct;85(19):9749-66</RefSource>
                <PMID Version="1">21813604</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem J. 2011 Dec 1;440(2):185-93</RefSource>
                <PMID Version="1">21895608</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007096</RefSource>
                <PMID Version="1">22229121</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cold Spring Harb Perspect Med. 2012;2(8). pii: a006866. doi: 10.1101/cshperspect.a006866</RefSource>
                <PMID Version="1">22908191</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2012 Oct 11;490(7419):283-7</RefSource>
                <PMID Version="1">22854780</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2012 Oct 26;338(6106):524-8</RefSource>
                <PMID Version="1">23112332</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Eng Des Sel. 2012 Dec;25(12):813-20</RefSource>
                <PMID Version="1">22942393</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2012 Nov 30;287(49):40841-9</RefSource>
                <PMID Version="1">23043104</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Viruses. 2012 Nov;4(11):3020-43</RefSource>
                <PMID Version="1">23202514</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2013 Jan;251(1):113-24</RefSource>
                <PMID Version="1">23278744</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Retrovirology. 2013;10:4</RefSource>
                <PMID Version="1">23305456</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Commun. 2013;4:1674</RefSource>
                <PMID Version="1">23575678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2013 Jul;87(13):7516-25</RefSource>
                <PMID Version="1">23637402</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2013 Dec;9(12):e1003835</RefSource>
                <PMID Version="1">24367265</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2014 Jan 23;505(7484):509-14</RefSource>
                <PMID Version="1">24356306</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Virology. 2003 Jan 20;305(2):318-29</RefSource>
                <PMID Version="1">12573577</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 2003 Jun 9;161(5):945-56</RefSource>
                <PMID Version="1">12796480</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2004 Jan;78(2):1026-31</RefSource>
                <PMID Version="1">14694135</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2004 Jan 19;199(2):283-93</RefSource>
                <PMID Version="1">14734528</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2004 Apr;78(7):3429-35</RefSource>
                <PMID Version="1">15016865</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1986 Sep 5;233(4768):1089-93</RefSource>
                <PMID Version="1">3016903</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 1991 Feb;138(2):421-6</RefSource>
                <PMID Version="1">1992767</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1996 Apr 5;272(5258):115-7</RefSource>
                <PMID Version="1">8600520</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>AIDS. 1996 Mar;10(3):241-6</RefSource>
                <PMID Version="1">8882662</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1997 Apr 15;158(8):3996-4007</RefSource>
                <PMID Version="1">9103471</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 1999 Jul;73(7):6089-92</RefSource>
                <PMID Version="1">10364363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 1999 Aug 23;146(4):893-904</RefSource>
                <PMID Version="1">10459022</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Microbiol Immunol. 2005;285:219-54</RefSource>
                <PMID Version="1">15609506</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Death Differ. 2005 Aug;12 Suppl 1:916-23</RefSource>
                <PMID Version="1">15719026</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biophys J. 2007 Mar 1;92(5):1777-83</RefSource>
                <PMID Version="1">17158573</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2007 Sep;81(18):9999-10008</RefSource>
                <PMID Version="1">17609279</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2008 Jan;82(2):1021-33</RefSource>
                <PMID Version="1">17989173</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Sci. 2008 Mar 1;121(Pt 5):685-94</RefSource>
                <PMID Version="1">18270265</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Life Sci. 2008 Oct;65(20):3134-44</RefSource>
                <PMID Version="1">18500445</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Retrovirology. 2008;5:111</RefSource>
                <PMID Version="1">19077194</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunology. 2009 Jun;127(2):237-48</RefSource>
                <PMID Version="1">19489128</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2009 Aug;83(15):7467-74</RefSource>
                <PMID Version="1">19458002</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2010;6(6):e1000956</RefSource>
                <PMID Version="1">20585556</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC3970140</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">v6031078</ArticleId>
            <ArticleId IdType="doi">10.3390/v6031078</ArticleId>
            <ArticleId IdType="pubmed">24608085</ArticleId>
            <ArticleId IdType="pmc">PMC3970140</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
